US FDA•United StatesCRL•Complete Response Letter
Complete Response Letter NDA 505b1 210168 (Mar 22, 2024)
Issued March 22, 2024
Issued
March 22, 2024
Application
NDA 505b1 • 210168
Review center
CDER
Stage
Final Decision
Letter type
Complete Response Letter
Response due March 22, 2025Requires resubmission addressing deficiencies.
Document viewer
Read the FDA letter and send context to the co-pilot at any time.